1. Home
  2. TYGO vs ELTX Comparison

TYGO vs ELTX Comparison

Compare TYGO & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYGO
  • ELTX
  • Stock Information
  • Founded
  • TYGO 2007
  • ELTX 2011
  • Country
  • TYGO United States
  • ELTX United States
  • Employees
  • TYGO N/A
  • ELTX N/A
  • Industry
  • TYGO Semiconductors
  • ELTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TYGO Technology
  • ELTX Health Care
  • Exchange
  • TYGO Nasdaq
  • ELTX Nasdaq
  • Market Cap
  • TYGO 116.0M
  • ELTX 121.7M
  • IPO Year
  • TYGO N/A
  • ELTX N/A
  • Fundamental
  • Price
  • TYGO $2.57
  • ELTX $10.75
  • Analyst Decision
  • TYGO Strong Buy
  • ELTX Strong Buy
  • Analyst Count
  • TYGO 1
  • ELTX 2
  • Target Price
  • TYGO $6.00
  • ELTX $11.00
  • AVG Volume (30 Days)
  • TYGO 708.2K
  • ELTX 73.1K
  • Earning Date
  • TYGO 11-05-2025
  • ELTX 11-12-2025
  • Dividend Yield
  • TYGO N/A
  • ELTX N/A
  • EPS Growth
  • TYGO N/A
  • ELTX N/A
  • EPS
  • TYGO N/A
  • ELTX N/A
  • Revenue
  • TYGO $74,405,000.00
  • ELTX N/A
  • Revenue This Year
  • TYGO $94.76
  • ELTX N/A
  • Revenue Next Year
  • TYGO $23.23
  • ELTX N/A
  • P/E Ratio
  • TYGO N/A
  • ELTX N/A
  • Revenue Growth
  • TYGO 52.31
  • ELTX N/A
  • 52 Week Low
  • TYGO $0.58
  • ELTX $4.05
  • 52 Week High
  • TYGO $2.58
  • ELTX $12.62
  • Technical
  • Relative Strength Index (RSI)
  • TYGO 75.36
  • ELTX 47.15
  • Support Level
  • TYGO $2.33
  • ELTX $10.65
  • Resistance Level
  • TYGO $2.58
  • ELTX $11.26
  • Average True Range (ATR)
  • TYGO 0.20
  • ELTX 0.46
  • MACD
  • TYGO 0.02
  • ELTX -0.08
  • Stochastic Oscillator
  • TYGO 90.10
  • ELTX 5.08

About TYGO Tigo Energy Inc.

Tigo Energy Inc designs solar power conversion and storage products that provide customers with more choice and flexibility. Its mission is to deliver smart hardware and software solutions that enhance safety, increase energy yield, and lower operating costs of residential, commercial, and utility-scale solar systems. Geographically the company generates revenue from EMEA, Americas, and APAC.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

Share on Social Networks: